Health disparities: Exploring the ethics of orphan drugs

被引：6
|
作者：
Kinney, Justin [1 ]
机构：
[1] Loma Linda Univ, Sch Pharm, Bioeth Program, Loma Linda, CA 92350 USA
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2014年 / 71卷 / 09期
关键词：
D O I：
10.2146/ajhp130348
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：692 / 693
页数：2
相关论文
共 50 条
  • [1] HEALTH MINISTERS TO HELP ORPHAN DRUGS
    WATSON, R
    [J]. BRITISH MEDICAL JOURNAL, 1995, 310 (6994): : 1557 - 1558
  • [2] HEALTH ECONOMICS OF ORPHAN DRUGS IN JAPAN
    Zhang, M.
    Gulati, D.
    Duttagupta, S.
    Chalmers, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S55 - S55
  • [3] Ethics of patient activation: exploring its relation to personal responsibility, autonomy and health disparities
    Gibert, Sophia H.
    DeGrazia, David
    Danis, Marion
    [J]. JOURNAL OF MEDICAL ETHICS, 2017, 43 (10) : 670 - 675
  • [4] Budget-impact of drugs for orphan diseases (orphan drugs) in the Israeli health basket: a longitudinal analysis
    Morginstin, Tal
    Hammerman, Ariel
    Triki, Noa
    Weinreb, Baruch
    [J]. ISRAEL JOURNAL OF HEALTH POLICY RESEARCH, 2019, 8 (01):
  • [5] Orphan drugs and orphan diseases
    Campos-Castelló, J
    [J]. REVISTA DE NEUROLOGIA, 2001, 33 (03) : 216 - 220
  • [6] ORPHAN DRUGS: HEALTH TECHNOLOGY ASSESSMENT AND PRICING IN EUROPE
    Jaroslawski, S.
    Toumi, M.
    Korchagina, D.
    Jadot, G.
    [J]. VALUE IN HEALTH, 2018, 21 : S24 - S24
  • [7] Orphan drugs: A problem of public health and an economic stake
    Brandissou, S
    Yagoubi, N
    Hasselot, N
    [J]. THERAPIE, 1996, 51 (06): : 647 - 653
  • [8] Exploring emerging technologies using metaphors - A study of orphan drugs and pharmacogenomics
    Boon, Wouter
    Moors, Ellen
    [J]. SOCIAL SCIENCE & MEDICINE, 2008, 66 (09) : 1915 - 1927
  • [9] ORPHAN DRUGS
    LYLE, WH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (15): : 813 - 814
  • [10] ORPHAN DRUGS
    BLANCHARD, T
    [J]. NATURE, 1992, 358 (6387) : 534 - 534
12345